RXST
RxSightยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
RXST Profile
Rxsight, Inc.
A developer of photorefractive keratectomy (PRK) and laser-assisted in situ keratomileusis (LASIK) treatments for vision correction
Healthcare Equipment and Supplies
03/05/1997
07/30/2021
NASDAQ Stock Exchange
498
12-31
Common stock
100 Columbia, Aliso Viejo, California 92656
--
RxSight, Inc., was incorporated in California on March 5, 1997 and re-registered in Delaware on July 6, 2021. The company is a commercial-stage medical technology company focused on improving vision in patients following cataract surgery. The company's proprietary RxSight dimmable lens system, consisting of the company's RxSight dimmable lens, RxSight projection device and accessories, is the first and only commercially available intraocular lens technology that enables physicians to customize and optimize vision for patients after cataract surgery.
